Description
Lalap is indicated as monotherapy and adjunctive therapy in the treat- ment of partial-onset seizures with or without secondary generalization in adults, adolescents and children from 4 years of age with epilepsy.
Additional information
| brand | Genix Pharma Private |
|---|
